Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate Monotherapy in Recently Diagnosed Partial-Onset Seizures
NCT00230698Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Nov 1995
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of topiramate in epilepsy (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Time to exit during the double blind phase. Started Nov 1995; status: completed.
02
Drugs
topiramate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00230698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00230698.